Antengene (FRA:722) FFO


FRA:722 Antengene Corp Ltd FRA:722
40 GF Score
Price €0.35
GF Value €0.16
! 5 Warning Signs
View Full Analysis

What is Antengene FFO?

FFO (Funds from operations) only applies to REITs.

FRA:722
40GF Score
Antengene Corp Ltd FRA:722
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Antengene (FRA:722) Overvalued in 2026?

Based on GuruFocus' analysis, Antengene stock appears to be overvalued. The current stock price of €0.35 is trading 117.5% above its estimated GF Value™ of €0.16.

Key valuation signals for FRA:722:

  • FFO:
  • GF Value™: €0.16 vs. price of €0.35 (117.5% above fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the FRA:722 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Antengene Business Description

Other Exchanges 06996:Hong Kong
Address 1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN
Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically, it operates in the Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.
40GF Score

Get the complete analysis for FRA:722

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.35
Price
€0.16
GF Value